Skip to main content

Advertisement

Log in

A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage

  • Maternal-Fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

In India, two third of maternal deaths occur in rural areas where there is lack of transportation facilities, lack of refrigeration to store the injectable uterotonic drug such as oxytocin, lack of skilled personnel to administer them and lack of sterile syringes and needles. Hence, this study was conceived to evaluate misoprostol as a safe, effective, easily administered non-parenteral drug in the prevention of postpartum hemorrhage.

Methods

This study was conducted during the period from August 2012 to July 2014. Low risk women with singleton pregnancy at term admitted for vaginal delivery were eligible for the study. A total of 500 women were randomized to two groups, 250 in each group, either to receive 400 mcg misoprostol sublingually or 10 units oxytocin intramuscularly at the delivery of anterior shoulder. Patient factors, labor parameters, blood loss and side effects were noted.

Results

The women in both the groups were well matched with respect to age, parity, gestational age and labor parameters. There was statistical significance in the blood loss (p = 0.04) between the two groups. The average blood loss was 70 ml in misoprostol group and 75 ml in oxytocin group. Shivering was the statistically significant side effect (p = 0.004) in the misoprostol group and nausea was the statistically significant side effect (p = 0.003) in the oxytocin group.

Conclusions

Sublingual misoprostol is as effective as intramuscular oxytocin as a prophylactic oxytocic in the active management of third stage of labor for prevention of postpartum hemorrhage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. The World Health Report 2005—make every mother and child count [Internet]. http://www.who.int/whr/2005/en/. Accessed 3 Sep 2014

  2. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367(9516):1066–1074

    Article  PubMed  Google Scholar 

  3. American College of Obstetricians and Gynecologists (2006) ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 108(4):1039–1047

    Article  Google Scholar 

  4. India SRS Special Bulletin on Maternal Mortality 2010–12 [Internet]. http://ghdx.healthdata.org/record/india-srs-special-bulletin-maternal-mortality-2010-2012. Accessed 1 Sep 2014

  5. Bellad MB, Tara D, Ganachari MS, Mallapur MD, Goudar SS, Kodkany BS et al (2012) Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial. BJOG 119(8):975–986

    Article  CAS  PubMed  Google Scholar 

  6. Elati A, Elmahaishi MS, Elmahaishi MO, Elsraiti OA, Weeks AD (2011) The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual doses. BJOG 118(4):466–473

    Article  CAS  PubMed  Google Scholar 

  7. Bohlmann Michael K, Rath Werner (2014) Medical prevention and treatment of postpartum hemorrhage: a comparison of different guidelines. Arch Gynecol Obstet 289:555–567

    Article  PubMed  Google Scholar 

  8. Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17(2):332–336

    Article  CAS  PubMed  Google Scholar 

  9. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ (2004) Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 1:CD000494

    PubMed  Google Scholar 

  10. Alfirevic Z, Blum J, Walraven G, Weeks A, Winikoff B (2007) Prevention of postpartum hemorrhage with misoprostol. Int J Gynecol Obstet 1(99):S198–S201

    Article  Google Scholar 

  11. Chaudhuri P, Biswas J, Mandal A (2012) Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women. Int J Gynaecol Obstet 116(2):138–142

    Article  CAS  PubMed  Google Scholar 

  12. Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S et al (2011) Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG 118(3):353–361

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. El-Refaey H, O’Brien P, Walder J, Rodeck C (2000) The misoprostol third stage of labour study: a randomized controlled comparison between orally administered misoprostol and standard management. BJOG 107:1104–1110

    Article  CAS  PubMed  Google Scholar 

  14. Tixier Hervé, Boucard Carole, Ferdynus Cyril, Douvier Serge, Sagot Paul (2011) Interest of using an underbuttocks drape with collection pouch for early diagnosis of postpartum hemorrhage. Arch Gynecol Obstet 283:25–29

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Authors do not report any conflicts of interest.

Ethical standard

This study has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

All women gave their informed consent prior to their inclusion in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Veena.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Priya, G.P., Veena, P., Chaturvedula, L. et al. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage. Arch Gynecol Obstet 292, 1231–1237 (2015). https://doi.org/10.1007/s00404-015-3763-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-015-3763-5

Keywords

Navigation